Un nouveau traitement en essai clinique chez un premier enfant achondroplase en France

Type 1 Interferon Deficiency: A Blood based Signature for Detecting Patients at Risk of Severe Covid-19

In a study published in Science on July 13, teams from AP-HP, Inserm, Université of Paris, Institut Pasteur and Institut Imagine describe a unique and unexpected immunological phenotype in severe and critical patients, consisting of a severely impaired response of interferon (IFN) ...